blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1554586

EP1554586 - Identification of drugs against mycobacteria [Right-click to bookmark this link]
Former [2005/29]SCREENING METHOD
[2009/45]
StatusNo opposition filed within time limit
Status updated on  14.01.2011
Database last updated on 14.09.2024
Most recent event   Tooltip19.10.2012Lapse of the patent in a contracting state
New state(s): TR		published on 21.11.2012  [2012/47]
Applicant(s)For all designated states
Council of Scientific and Industrial Research
Rafi Marg
New Delhi 110 001 / IN
[2010/10]
Former [2005/29]For all designated states
Council of Scientific and Industrial Research
Rafi Marg
New Delhi 110 001 / IN
Inventor(s)01 / TYAGI, Jaya S., All India Ins. of Medical Sciences
Dept. of Biotechnology, Ansari Nagar
110 029 New Delhi / IN
02 / SAINI, Deepak K. All India Ins. of Medical Sciencs
Dept. of Biotechnology, Ansari Nagar
110 029 New Delhi / IN
 [2005/29]
Representative(s)Long, Giorgio
Jacobacci & Partners S.p.A.
Via Senato, 8
20121 Milano / IT
[N/P]
Former [2005/29]Long, Giorgio
Jacobacci & Partners S.p.A. Via Senato, 8
20121 Milano / IT
Application number, filing date03751127.616.10.2003
[2005/29]
WO2003IB04555
Priority number, dateUS20020418837P16.10.2002         Original published format: US 418837 P
[2005/29]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2004036224
Date:29.04.2004
Language:EN
[2004/18]
Type: A2 Application without search report 
No.:EP1554586
Date:20.07.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 29.04.2004 takes the place of the publication of the European patent application.
[2005/29]
Type: B1 Patent specification 
No.:EP1554586
Date:10.03.2010
Language:EN
[2010/10]
Search report(s)International search report - published on:EP02.09.2004
ClassificationIPC:G01N33/68, A61P31/04, // A61K31/10
[2009/45]
CPC:
C12Q1/18 (EP,US); A61K45/06 (EP,US); A61P31/04 (EP);
C12Q1/485 (EP,US); G01N33/6893 (EP,US); G01N2500/00 (EP,US)
Former IPC [2005/29]G01N33/68, A61K31/00, A61P31/04
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2005/29]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:Identifikation von Arzneimittel gegen Mykobakterien[2009/45]
English:Identification of drugs against mycobacteria[2009/45]
French:Identification des médicaments contre des mycobactéries[2009/45]
Former [2005/29]SCREENINGVERFAHREN
Former [2005/29]SCREENING METHOD
Former [2005/29]PROCEDE DE CRIBLAGE
Entry into regional phase29.04.2005National basic fee paid 
29.04.2005Designation fee(s) paid 
29.04.2005Examination fee paid 
Examination procedure14.05.2004Request for preliminary examination filed
International Preliminary Examining Authority: EP
29.04.2005Examination requested  [2005/29]
08.09.2006Despatch of a communication from the examining division (Time limit: M06)
19.03.2007Reply to a communication from the examining division
20.08.2007Despatch of a communication from the examining division (Time limit: M06)
20.02.2008Reply to a communication from the examining division
12.10.2009Communication of intention to grant the patent
24.12.2009Fee for grant paid
24.12.2009Fee for publishing/printing paid
Opposition(s)13.12.2010No opposition filed within time limit [2011/07]
Fees paidRenewal fee
07.10.2005Renewal fee patent year 03
21.08.2006Renewal fee patent year 04
21.08.2007Renewal fee patent year 05
22.08.2008Renewal fee patent year 06
20.08.2009Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT10.03.2010
BE10.03.2010
CY10.03.2010
CZ10.03.2010
DK10.03.2010
EE10.03.2010
FI10.03.2010
IT10.03.2010
NL10.03.2010
RO10.03.2010
SE10.03.2010
SI10.03.2010
SK10.03.2010
TR10.03.2010
BG10.06.2010
GR11.06.2010
ES21.06.2010
PT12.07.2010
HU11.09.2010
IE16.10.2010
LU16.10.2010
CH31.10.2010
LI31.10.2010
MC31.10.2010
[2012/47]
Former [2012/44]AT10.03.2010
BE10.03.2010
CY10.03.2010
CZ10.03.2010
DK10.03.2010
EE10.03.2010
FI10.03.2010
IT10.03.2010
NL10.03.2010
RO10.03.2010
SE10.03.2010
SI10.03.2010
SK10.03.2010
BG10.06.2010
GR11.06.2010
ES21.06.2010
PT12.07.2010
HU11.09.2010
IE16.10.2010
LU16.10.2010
CH31.10.2010
LI31.10.2010
MC31.10.2010
Former [2012/42]AT10.03.2010
BE10.03.2010
CY10.03.2010
CZ10.03.2010
DK10.03.2010
EE10.03.2010
FI10.03.2010
IT10.03.2010
NL10.03.2010
RO10.03.2010
SE10.03.2010
SI10.03.2010
SK10.03.2010
BG10.06.2010
GR11.06.2010
ES21.06.2010
PT12.07.2010
HU11.09.2010
IE16.10.2010
CH31.10.2010
LI31.10.2010
MC31.10.2010
Former [2011/47]AT10.03.2010
BE10.03.2010
CY10.03.2010
CZ10.03.2010
DK10.03.2010
EE10.03.2010
FI10.03.2010
IT10.03.2010
NL10.03.2010
RO10.03.2010
SE10.03.2010
SI10.03.2010
SK10.03.2010
BG10.06.2010
GR11.06.2010
ES21.06.2010
PT12.07.2010
IE16.10.2010
CH31.10.2010
LI31.10.2010
MC31.10.2010
Former [2011/38]AT10.03.2010
BE10.03.2010
CY10.03.2010
CZ10.03.2010
DK10.03.2010
EE10.03.2010
FI10.03.2010
IT10.03.2010
NL10.03.2010
RO10.03.2010
SE10.03.2010
SI10.03.2010
SK10.03.2010
BG10.06.2010
GR11.06.2010
ES21.06.2010
PT12.07.2010
CH31.10.2010
LI31.10.2010
MC31.10.2010
Former [2011/24]AT10.03.2010
BE10.03.2010
CY10.03.2010
CZ10.03.2010
DK10.03.2010
EE10.03.2010
FI10.03.2010
IT10.03.2010
NL10.03.2010
RO10.03.2010
SE10.03.2010
SI10.03.2010
SK10.03.2010
BG10.06.2010
GR11.06.2010
ES21.06.2010
PT12.07.2010
MC31.10.2010
Former [2011/15]AT10.03.2010
BE10.03.2010
CY10.03.2010
CZ10.03.2010
DK10.03.2010
EE10.03.2010
FI10.03.2010
IT10.03.2010
NL10.03.2010
RO10.03.2010
SE10.03.2010
SI10.03.2010
SK10.03.2010
BG10.06.2010
GR11.06.2010
ES21.06.2010
PT12.07.2010
Former [2011/08]AT10.03.2010
BE10.03.2010
CY10.03.2010
CZ10.03.2010
DK10.03.2010
EE10.03.2010
FI10.03.2010
NL10.03.2010
RO10.03.2010
SE10.03.2010
SI10.03.2010
SK10.03.2010
BG10.06.2010
GR11.06.2010
ES21.06.2010
PT12.07.2010
Former [2011/07]AT10.03.2010
BE10.03.2010
CY10.03.2010
CZ10.03.2010
DK10.03.2010
EE10.03.2010
FI10.03.2010
NL10.03.2010
RO10.03.2010
SE10.03.2010
SI10.03.2010
SK10.03.2010
BG10.06.2010
GR11.06.2010
ES21.06.2010
Former [2010/51]AT10.03.2010
BE10.03.2010
CY10.03.2010
CZ10.03.2010
EE10.03.2010
FI10.03.2010
NL10.03.2010
RO10.03.2010
SE10.03.2010
SI10.03.2010
SK10.03.2010
BG10.06.2010
GR11.06.2010
ES21.06.2010
Former [2010/49]AT10.03.2010
BE10.03.2010
CY10.03.2010
CZ10.03.2010
EE10.03.2010
FI10.03.2010
NL10.03.2010
RO10.03.2010
SE10.03.2010
SI10.03.2010
SK10.03.2010
GR11.06.2010
ES21.06.2010
Former [2010/48]AT10.03.2010
BE10.03.2010
CY10.03.2010
EE10.03.2010
FI10.03.2010
NL10.03.2010
RO10.03.2010
SE10.03.2010
SI10.03.2010
GR11.06.2010
ES21.06.2010
Former [2010/46]AT10.03.2010
FI10.03.2010
NL10.03.2010
SI10.03.2010
GR11.06.2010
ES21.06.2010
Former [2010/45]AT10.03.2010
FI10.03.2010
NL10.03.2010
SI10.03.2010
Former [2010/38]AT10.03.2010
FI10.03.2010
SI10.03.2010
Former [2010/37]AT10.03.2010
SI10.03.2010
Former [2010/36]SI10.03.2010
Cited inInternational search[X]US4975280  (SCHACHT ETIENNE [BE], et al) [X] 17-21 * column 2, line 18 - line 26; examples 1,2; claims 1,5,9,60,61 *;
 [A]WO0248391  (INST OF MOLECUL & CELL BIOLOGY [SG], et al) [A] 1-21 * page 2, line 9 - line 30; examples 5-7; claims 1-7,12 * * page 15, line 25 - page 16, line L *;
 [X]  - SANDER P ET AL, "Contribution of the multidrug efflux pump LfrA to innate mycobacterial drug resistance.", FEMS MICROBIOLOGY LETTERS. 1 DEC 2000, (20001201), vol. 193, no. 1, ISSN 0378-1097, pages 19 - 23, XP002285066 [X] 8-16 * page 21, column L, line 18 - page 22, column L, line 3; table 1 *

DOI:   http://dx.doi.org/10.1016/S0378-1097(00)00456-0
 [X]  - DARAFARIN AMIR ET AL, "Synthesis and antimicrobial activities of some 2-mercaptobenzimidazole derivatives", BIOSIS, BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US, (1992), Database accession no. PREV199395117347, XP002285067 [X] 8-16 * abstract *
 [DA]  - MAYURI ET AL, "Molecular analysis of the dormancy response in Mycobacterium smegmatis: expression analysis of genes encoding the DevR-DevS two-component system, Rv3134c and chaperone alpha-crystallin homologues.", FEMS MICROBIOLOGY LETTERS. 4 JUN 2002, (20020604), vol. 211, no. 2, ISSN 0378-1097, pages 231 - 237, XP002285065 [DA] 1-21 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0378-1097(02)00684-5
 [DA]  - DASGUPTA N ET AL, "CHARACTERIZATION OF A TWO-COMPONENT SYSTEM, DEVR-DEVS, OF MYCOBACTERIUM TUBERCULOSIS", TUBERCLE, LONGMAN GROUP UK LTD., HARLOW, GB, (2000), vol. 80, no. 3, ISSN 0041-3879, pages 141 - 159, XP009024893 [DA] 1-21 * page 141, column L, paragraph 1 - page 142, column L, paragraph 1 * * page 144, column L, paragraph 4 - column R, paragraph 1 * * page 145, column R, paragraph 3 - page 146, column R, line L * * page 152, column R, paragraph L - page 155, column R, paragraph 1; figure 7 * * page 157, column L, paragraph 2 - page 158, column L, paragraph 2 *
 [A]  - SAINI D K ET AL, "Cloning, Overexpression, Purification, and Matrix-Assisted Refolding of DevS (Rv 3132c) Histidine Protein Kinase of Mycobacterium tuberculosis", PROTEIN EXPRESSION AND PURIFICATION, ACADEMIC PRESS, SAN DIEGO, CA, US, (200206), vol. 25, no. 1, ISSN 1046-5928, pages 203 - 208, XP004467025 [A] 1-21 * abstract * * page 203, column R, line 17 - page 205, column L, line 16 * * page 206, column L, paragraph L - column R, line 3 *

DOI:   http://dx.doi.org/10.1006/prep.2002.1628
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.